News and Trends 16 Oct 2019 UK Firm Raises €51M to Repurpose Drugs for Rare Diseases Using AI …AI to collect extensive medical research data about rare diseases and existing drugs. The AI uses these data to predict which drugs could treat incurable rare diseases such as fragile… October 16, 2019 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 16 Mar 2023 Inspire Biotherapeutics launches to target lung diseases through gene therapy …platform can be applied to treat many lung diseases. These include interstitial lung disease, pulmonary fibrosis, other monogenic lung diseases and cystic fibrosis. Inspire Biotherapeutics’ scientific founders – Bernard Thébaud,… March 16, 2023 - 2 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 13 Jun 2017 German Biotech Raises €25M to Fuel Diagnostics of Rare Diseases Centogene has raised €25M in a Series A round to support the global expansion of its genome analysis platform, which is specialized in rare diseases. The German biotech Centogene is… June 13, 2017 - 2 minutesmins - By Melanie De Almeida Share WhatsApp Twitter Linkedin Email
In Depth 31 Jan 2017 Biologicals on the Brain: Biotech in Neurodegenerative Disease …particularly focused on rare diseases with a significant CNS component. We feel that our technology platform can be leveraged across a substantial number of these rare diseases that affect the… January 31, 2017 - 7 minutesmins - By Diana Kwon Share WhatsApp Twitter Linkedin Email
Best in Biotech 12 Apr 2023 6 new vaccines being developed for difficult-to-treat diseases …are able to prevent more than 20 life-threatening diseases, in turn preventing 3.5 to five million deaths every year from diseases such as diphtheria, tetanus, influenza and measles. Vaccines are… April 12, 2023 - 10 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
News and Trends 28 Feb 2017 It’s Global Rare Disease Day! What Cures is Biotech Cooking Up? …faced by patients with a rare disease. In the EU alone, rare diseases affect 30 million citizens, and there are over 6,000 rare diseases that affect from dozens to thousands… February 28, 2017 - 5 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
Best in Biotech 1 Jun 2023 Five ophthalmology biotech companies to look out for There are hundreds of different eye diseases, with some of the most common major eye diseases including age-related macular degeneration (AMD) – an age-related eye disease that can blur central… June 1, 2023 - 6 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 16 Oct 2024 JAK inhibitors: Are they a good option for treating inflammatory diseases and cancer? Janus Kinase (JAK) inhibitors, a type of kinase inhibitor, are a popular class of drugs in the biopharma industry. Several have been approved to treat inflammatory diseases and cancer, and… October 16, 2024 - 9 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
News and Trends 19 Oct 2022 CDF15 cytokine a promising therapeutic target against type 2 diabetes …at the Biomedical Research Networking Center in Diabetes and Associated Metabolic Disorders (CIBERDEM). Beneficial effects on metabolism Type 2 diabetes is a complex metabolic disease characterized mainly by an excessive… October 19, 2022 - 5 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
Best in Biotech 21 Nov 2024 Eight areas where gene therapy shines …eye diseases Gene therapy offers an interesting application in addressing ophthalmological disorders, especially inherited retinal diseases (IRDs) that cause gradual vision loss. The idea is to deliver functional genes directly… November 21, 2024 - 12 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Best in Biotech 15 Mar 2017 What are the Best Countries to Recruit Biotech Talents in 2017? …money-magnet. Intellia Therapeutics won the IPO funding race of therapeutic CRISPR. Intarcia Therapeutics focuses on drug delivery for metabolic diseases like diabetes, raised $225M in its last round. Gingko Bioworks… March 15, 2017 - 10 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
News and Trends 21 Oct 2024 Turning back time with cellular reprogramming: Shift raises $16 million in seed funding …cells, often referred to as “zombie cells.” These cells have stopped dividing but remain metabolically active, secreting pro-inflammatory factors that damage surrounding tissues and contribute to age-related diseases. Senolytic drugs… October 21, 2024 - 9 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email